Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IRF5 produced by kidney macrophages promotes polycystic kidney disease

ABSTRACT: IRF5 produced by kidney macrophages promotes polycystic kidney disease

PROVIDER: PRJNA525686 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8670600.fastq.gz	Fastqsanger.gz
	SRR8670610.fastq.gz	Fastqsanger.gz
	SRR8670601.fastq.gz	Fastqsanger.gz
	SRR8670611.fastq.gz	Fastqsanger.gz
	SRR8670602.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

IRF5 produced by kidney macrophages promotes polycystic kidney disease

Project description:We show that Pkd1 mice have higher levels of kidney IRF5 compared to control mice and that IRF5 expression is found predominantly in macrophage populations in the kidney. Suppressing IRF5 with an antisense oligonucleotide (ASO) decreased kidney IRF5, the total number of kidney macrophages, pro-inflammatory cytokine production, and attenuated kidney cyst growth.

2025-02-18 | GSE127881 | GEO

Polycystic Kidney Disease Progression Expression Analysis

Project description:Polycystic Kidney Disease (PKD) is a genetic disease of the kidney characterized by the gradual replacement of normal kidney parenchyma by fluid-filled cysts and fibrotic tissue. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused by mutations in the PKD1 or PKD2 gene. Here we present an RNASeq experiment designed to investigate the effect of a kidney specific and Tamoxifen inducible knockout of the Pkd1 gene in mice. The Pkd1cko mice were harvested at different time points 2-weeks, 3-weeks, 5-weeks, 10.5-weeks, 11-weeks and 15-weeks after gene inactivation.

2019-12-24 | E-MTAB-8086 | biostudies-arrayexpress

Expression profiling of Pkd1cko mice: A model of Polycystic Kidney Disease

Project description:Polycystic Kidney Disease (PKD) is a genetic disease of the kidney characterized by the gradual replacement of normal kidney parenchyma by fluid-filled cysts and fibrotic tissue. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused by mutations in the PKD1 or PKD2 gene. Here we present an RNASeq experiment designed to investigate the effect of a kidney specific and Tamoxifen inducible knockout of the Pkd1 gene in mice. 7 mice were grouped into two groups, 4 Tamoxifen treated mice which develop an adult onset Polycystic Kidney Disease phenotype and 3 untreated mice which have WT phenotype.

2016-06-01 | E-MTAB-4086 | biostudies-arrayexpress

Polycystic Kidney Disease Progression Expression Analysis

Project description:Polycystic Kidney Disease Progression Expression Analysis

| PRJEB35921 | ENA

Kidney Transcriptome and Polycystic Kidney Disease Genes in Zebrafish

Project description:Kidney Transcriptome and Polycystic Kidney Disease Genes in Zebrafish

| PRJNA932807 | ENA

Expression data from renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients

Project description:To elucidate the molecular pathways that modulate renal cyst growth in autosomal dominant polycystic kidney disease (ADPKD) Keywords: Disease state analysis

2009-08-14 | GSE7869 | GEO

Next Generation Sequencing Technologies to Investigate Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Project description:Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare paediatric disease primarily caused by mutations in the gene PKHD1. ARPKD presents with considerably clinical variability which is linked to the type of PKHD1 mutation but not position. Animal models of Polycystic Kidney Disease (PKD) suggest there is a complex genetic landscape with genetic modifiers as a potential cause of disease variability. Transcriptomic analysis identified a considerable number of genes linked to cellular metabolism and development. Amongst these genes were those linked to WNT signalling. Two individuals in this cohort had the same mutations in PKHD1 but different rates of kidney disease progression. Amongst the transcriptomic differences of these two individuals were differences in the expression changes of WNT genes.

2024-09-06 | GSE242476 | GEO

Single Cell Multiomics Profiling for the Mouse Polycystic Kidney Disease

Project description:We performed multiomics analysis; single nucleus RNA-seq (snRNA-seq) combined with ATAC (snATAC-seq) with 10XGenomics Multiome platform to generate cell-type-specific gene expression and chromatin accessibility atlas of the mouse polycystic kidney disease on a time course.

2024-10-02 | GSE268494 | GEO

Multiomics analyses reveal the role of Glis3 in polycystic kidney disease

Project description:We performed unbiased transcriptional profiling and chromatin accessibility analyses on adult kidney tissues from allelic series of Pkd1 and Glis3 inactivation mouse models. Glis3 is a modifer of cyst progression whose inactivation exacerbates polycystic kidney disease. Through the integration of multiomic datasets, we generated hypotheses to explain the worsening phenotype observed in Pkd1 and Glis3 double mutants.

2025-07-30 | GSE299238 | GEO

Identify signature genes associated with nanoparticle carrying IRF5 mRNA treatment in bone marrow derrived macrophages

Project description:To identify signature genes associated with nanoparticles carrying IRF5 mRNA treatment on primary macrophages, we analyzed 770 genes in 19 different pathways and processes across 7 different myeloid cell types.

2019-08-09 | GSE120254 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data